Results of subsequent prospective investigations [13,14,15,16,17,18,19,20,21,22,23,24] that were conducted in the early 1990s were somewhat discordant as to the contribution of plasma Lp(a) to the development of CAD, and this is why the scientific interest in Lp(a) was dampened, dragging this lipoprotein temporarily out of the picture. Here, LPA is linked to coronary artery disorder.